WhaleWatchWhaleWatch
Smart Money Alert
Alpex Solar logo

Alpex Solar

DecreasedQuarterly
ALPEXSOLAROther Electrical EquipmentMarket Cap₹2K Cr
Stake
1.22% → 1.17%
AS
Astorne Capital
Foreign Investor
The move

Astorne Capital decreased its stake in Alpex Solar from 1.22% to 1.17% by selling 11,000 shares. The value of the shares sold is ₹94.22 lakh, calculated at a share price of ₹856.55.

About Alpex Solar
Visit stock

A manufacturer of photovoltaic modules and provider of comprehensive solar energy solutions, Alpex Solar serves the renewable energy sector across India. The company designs and installs complete solar systems for residential, commercial, and industrial customers. Since its incorporation in 2008, it has focused on delivering high-quality solar equipment and turnkey energy solutions to support India's transition toward clean power generation.

About Astorne Capital
Visit investor

Astorne Capital is a Singapore-based variable capital company managed by fund manager Prosperitas Capital, investing in Indian listed and SME equities.

Get the next move the moment it happens.
Follow Astorne Capital and Alpex Solar on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Alpex Solar shareholdersAstorne Capital's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
AS
More moves by Astorne Capital
Arisinfra Solutions Limited
Direction, size, price and stake change for this move, with what it means for the company.
7 Aug 2026. Sign in to see this move
Innovision LimitedExited
Astorne Capital, which last reported a 1.55 percent stake in Innovision Limited, is no longer listed among the company's named shareholders, indicating either a complete exit or a reduction to below the 1 percent disclosure threshold.
INNOVISION22 Jul 2026
Read more
Sai Parenterals LimitedExited
Astorne Capital, which previously held a 1.15 percent stake in Sai Parenterals Limited, is no longer listed among its public shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
SAIPARENT21 Jul 2026
Read more
Arisinfra Solutions LimitedIncreased
Astorne Capital increased its stake in Arisinfra Solutions by purchasing 1,93,241 shares, raising its holding from 1.21% to 1.44%. The shares were valued at approximately ₹2.13 Cr, at a price of ₹110.39 per share.
ARIS20 Jul 2026
Read more
Senores Pharmaceuticals LimitedIncreased
Astorne Capital increased its stake in Senores Pharmaceuticals from 1.53% (705,346 shares) to 1.95% (897,350 shares), acquiring an additional 192,004 shares. The value of its increased holding is ₹12.93 Cr based on Senores Pharmaceuticals' share price of ₹1405.10.
SENORES20 Jul 2026
Read more
See all moves